DPYSL3 an outlier gene in triple-negative breast cancer
Breast Cancer Ireland is delighted with new research from Baylor College of Medicine (based in Houston, Texas, USA) that highlights DPYSL3 as an outlier gene in triple-negative breast cancer. It is typically associated with younger women diagnosed and for whom traditional standard treatments are generally prescribed.
There is a great need for continued investment into newer targeted therapies to help change the landscape of breast cancer treatment. For further details, please click on the below link: